uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Edarbi
Authorised
Human
Details
EMA number
EMEA/H/C/002293
ATC code
C09CA09
Authorisation
7 December 2011
Revision
12
EMA page
Therapeutic indication
Edarbi is indicated for the treatment of essential hypertension in adults.
MeSH:
Hypertension
Group:
Agents acting on the renin-angiotensin system
Active substances
azilsartan medoxomil
Marketing Authorisation Holder
Takeda Pharma A/S
MAH
Timeline
Filter by authority:
EMA
Edarbi authorised
7 Dec 2011
authorised
regulatory
Edarbi | uMedical